Anti Cancer Agents In Medicinal Chemistry

  • Home
  • FOR AUTHORS
  • ARTICLES
  • SUBSCRIBERS & CORPORATES
  • CONTENTS & ABSTRACTS
  • CONTACT US

Tuesday, January 3, 2017

Highlighted Article: Design, Synthesis and Evaluation of 5-pyridin-4-yl-2-thioxo-[1,3,4]oxadiazol-3-yl Derivatives as Anti-angiogenic Agents Targeting VEGFR-2

4:30 AM    No comments

Highlighted Article: Design, Synthesis and Evaluation of 5-pyridin-4-yl-2-thioxo-[1,3,4]oxadiazol-3-yl Derivatives as Anti-angiogenic Agents Targeting VEGFR-2


Email ThisBlogThis!Share to XShare to Facebook
Newer Post Older Post Home

0 comments:

Post a Comment

Social Profiles

TwitterFacebookGoogle PlusLinkedInEmail
  • Popular
  • Tags
  • Blog Archives

Blog Archive

  • ►  2018 (3)
    • ►  March (1)
    • ►  February (1)
    • ►  January (1)
  • ▼  2017 (35)
    • ►  November (1)
    • ►  October (4)
    • ►  September (2)
    • ►  August (4)
    • ►  June (4)
    • ►  May (3)
    • ►  April (4)
    • ►  March (4)
    • ►  February (3)
    • ▼  January (6)
      • Call For Paper
      • New Issue Published Anti Cancer Agents in Medicina...
      • Free Trial Request
      • Most Accessed Article: The Role of Tumor Associate...
      • Highlighted Article: Design, Synthesis and Evaluat...
      • Most Cited Article: MiR-138 and MiR-135 Directly T...
  • ►  2016 (20)
    • ►  December (6)
    • ►  November (5)
    • ►  October (5)
    • ►  June (4)

About

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases
Mutations of Chromatin Structure Regulating Genes in Human Malignancies
Targeting EZH2 for Cancer Therapy: Progress and Perspective
Disintegrins from Snake Venoms and their Applications in Cancer Research and Therapy
Thioredoxin Reductase and its Inhibitors

 

  • Blogroll

  • About

Copyright © Anti Cancer Agents In Medicinal Chemistry | Powered by Blogger
Design by NewWpThemes | Blogger Theme by Lasantha - Premium Blogger Templates | NewBloggerThemes.com